Toxic Epidermal Necrolysis (TEN) Back in Spotlight
By Andrea Gressman
On October 3, 2012, there was an article published by the Chicago Tribune featuring yet another victim of Toxic Epidermal Necrolysis (TEN), the more extreme condition of Stevens Johnson Syndrome. It is because of stories like this that the awareness is finally becoming more prevalent of the fatal risks of Stevens Johnson Syndrome.
Another Severe Case of Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)
One of the latest situations regarding Stevens Johnson Syndrome and Toxic Epidermal Necrolysis that has hit the national scene involves a young girl, Brianna Thompson. October 3, 2012, the Chicago Tribune ran a story regarding Miss Thompson’s situation. The fact that Miss Thompson recently underwent an experimental eye treatment to attempt to treat the Toxic Epidermal Necrolysis (TEN) that she had developed captured the national spotlight. When Miss Thompson was only 9 years of age, just 3 years ago, she broke out in a rash and had bloodshot eyes after simply taking Tylenol, a common household over-the-counter medication. She was later diagnosed with TEN. After her experimental eye treatment, Brianna fortunately has recovered from TEN.
The Symptoms and Side Effects of Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)
Stevens Johnson Syndrome begins as a skin condition as a result of an allergic reaction to a variety of common prescribed and OTC medications. Even ibuprofen has been known to create such reactions. SJS also affects the victim’s mucus membranes as a result of the allergic reaction. Sadly, the side effects that can result from Stevens Johnson Syndrome include blindness as well as death.
In the spring of 2011 the FDA released an announcement that the adverse reactions listed on the labels of Vibramycin, Doryx, and Mondox was going to be updated to include the possible side effect risk of Stevens Johnson Syndrome, as well as Toxic Epidermal Necrolysis.
In a recent publication of Dermatology Online Journal, they estimated that there have been 1-3 cases of TEN for every million people that have developed Stevens Johnson Syndrome. It has the mortality rate of 5%.
Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) Growing Number of Lawsuits
Many medication users are still very much in the dark about the potential side effect risk of developing Stevens Johnson Syndrome or Toxic Epidermal Necrolysis by taking a number of different medications. Most of these medications only note the potential outbreak of a skin rash and do not elaborate on what may actually be causing the rash. However, as more and more Stevens Johnson Syndrome lawsuits are filed, more people are becoming aware of the potentially deadly condition and those who are advocating for the consumer are gaining ground in getting the medications labels to accurately reflect the potential SJS side effect.
If you or your loved one has been diagnosed with Stevens Johnson Syndrome or Toxic Epidermal Necrolysis it is important that you know your legal rights. Visit the Stevens Johnson Syndrome (SJS) & Toxic Epidermal Necrolysis Class Action Lawsuit Investigation page right away to speak with a Stevens Johnson Syndrome lawsuit attorney.
Updated November 13th, 2012
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement